TLR3 and lung carcinoma: To further verify the above results, we used TLR3 agonist Poly(I:C) to treat lung cancer cells (A549) and found that the expressions of MYD88, Caspase 8, BIRC3 and PIK3R1 were in line with the expression of TLR3 (Figures 7B, C).